US › Healthcare

McKesson Corporation (MCK)

US · Healthcare · Medical Distribution

$830.43+0.40%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$96.30B
Revenue YoY
+6.0%
Net profit
$1.68B
Profit YoY
+33.5%
EPS
$11.69
EPS estimate
$11.57
Net margin
1.7%

EPS came in at 11.69 against a street estimate of 11.57 — a beat of 1.0%.

Key statistics

Market cap
$101.33B
P/E
21.6
Forward P/E
19.3
P/B
5.04
Book value
$-18.10
EPS (TTM)
$38.36
Dividend yield
0.37%
52-week high
$997.90
52-week low
$634.42
50-day MA
$790.06
200-day MA
$835.88
Beta
0.31

Analyst view

Analysts rate McKesson Corporation a buy (13 buy, 3 hold, 1 sell out of 17) with an average price target of $945.47.

Shareholding

Insiders
0.05%
Institutions
95.36%

Largest institutional holders

FundStake
Vanguard Group Inc10.34%
BlackRock Inc9.75%
Vanguard Capital Management, LLC6.80%
State Street Corp4.90%
FMR Inc3.08%
JPMorgan Chase & Co2.79%
Franklin Resources Inc2.62%
Geode Capital Management, LLC2.48%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for McKesson Corporation — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.